

2026 Featured Speakers
OCMF is honored to be featuring speakers from across a number of institutions and disciplines.

Keynote
Ursula Matulonis, MD
Chief of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School.
Topic: Targeting genomic vulnerabilities to improve ovarian cancer therapeutics

Keynote
Jose Conejo-Garcia, MD, PhD
Chair of the Department of Immunology at H. Lee Moffitt Cancer Research Institute and Professor of Immunology at Duke University School of Medicine.
Topic: Closing in: Cracking Ovarian Cancer's Resistance to Immunotherapy
Kate Chiappinelli, PhD
Targeting transposable elements to reverse ovarian cancer immune evasion
George Washington University
Fergus Couch, PhD
Precise risk estimation for inherited variants in cancer predisposition genes
Mayo Clinic
Stephanie Gaillard, MD, PhD
Harnessing Therapeutic Vulnerabilities in ARID1A mutated ovarian cancers
Johns Hopkins
Gordon Mills, MD, PhD
Improving the failure rate of Ovarian Cancer Clinical Trials
Oregon Health and Science University
Matthew Powell, MD
New targeted treatments to improve outcomes for women with endometrial cancers: recent clinical advances.
Washington University School of Medicine
Kathryn R. Taylor, PhD
The neural regulation of pediatric cancer
Memorial Sloan Kettering Cancer Center
Jeremy Chien, PhD
Genetic, epigenetic, and functional characterization of DTP cells in vitro and in situ in ovarian cancer
University of California - Davis
Analisa DiFeo, PhD
Unraveling Innovative Therapies through Tumor Analysis and Genetic Insights
University of Michigan School of Medicine
David Mutch, MD
Pearls and pitfalls of submitting a SPORE grant
Washington University School of Medicine
Amy Skubitz, PhD
Identification of ovarian cancer protein biomarkers in Pap tests
University of Minnesota
Jordyn Silverstein, MD
Claudin-6 as a novel therapeutic target in ovarian cancer
UCLA
Ashani Weeraratna, PhD
A Complex TiME: How aging drives tumor progression
Johns Hopkins
Andrea Wahner Hendrickson, MD
Clinical Trials in Ovarian Cancer
Mayo Clinic
